ST. LOUIS — Just a few years ago, Stereotaxis was on the brink of insolvency, losing millions of dollars a year with millions more in debt.
Now, the local medical device company is growing revenues, adding investors and leaving its longtime home in the Cortex technology district. It expects its new space, at the Globe Building in downtown St. Louis, to more than triple manufacturing capacity.
Stereotaxis CEO David Fischel said the new building is designed for collaboration.
“It can accommodate significant growth of the team,” he said.
Image: https://www.stltoday.com
